SHOULDER INNOVATIONS, INC.（SI）内部人交易：高管与董事近期交易
过去 18 个月，共有 17 位内部人为 SHOULDER INNOVATIONS, INC.（SI）报告了 92 笔 Form 4 交易（最近一笔 2026-10-06）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | BUCKMAN PAUL | 董事 | 买入 | 1,275 | $24,990 |
| 2026-10-06 | Tansey Casey M | 董事 | 买入 | 733 | $14,367 |
| 2026-10-06 | Hykes Andrew | 董事 | 买入 | 669 | $13,112 |
| 2026-10-06 | Sidow Kevin K. | 董事 | 买入 | 892 | $17,483 |
| 2026-09-14 | Ball Robert Joseph | CEO & Executive Chairman | 买入 | 89,233 | $187,282 |
| 2026-09-14 | Ball Robert Joseph | CEO & Executive Chairman | 卖出 | 10,175 | $187,706 |
| 2026-08-28 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 1,196 | $27,030 |
| 2026-08-24 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 3,900 | $88,140 |
| 2026-08-24 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 20,516 | $463,867 |
| 2026-08-24 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 681 | $15,404 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | 卖出 | 2,500 | $0 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | 卖出 | 8,314 | $167,101 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | 卖出 | 12,586 | $263,493 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | 卖出 | 1,600 | $34,211 |
| 2026-08-07 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 2,095 | $47,347 |
| 2026-08-07 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 7,338 | $166,132 |
| 2026-08-05 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 10,751 | $244,155 |
| 2026-08-05 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 99,812 | $2.3M |
| 2026-08-03 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 28,245 | $659,803 |
| 2026-08-03 | Gilde Healthcare Holding B.V. | 10% 以上股东 | 卖出 | 20,034 | $455,373 |
| 2026-06-29 | Sidow Kevin K. | 董事 | 买入 | 5,046 | $0 |
| 2026-06-29 | Hykes Andrew | 董事 | 买入 | 5,046 | $0 |
| 2026-06-29 | Buchholz Richard | 董事 | 买入 | 5,046 | $0 |
| 2026-06-29 | Tansey Casey M | 董事 | 买入 | 5,046 | $0 |
| 2026-06-29 | BUCKMAN PAUL | 董事 | 买入 | 5,046 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-06